Abstract
Angiotensin II (Ang II), a potent hypertrophic factor for vascular smooth muscle cells (VSMC), induces activation of the ras proto-oncogene product (Ras) and mitogen-activated protein (MAP) kinases, and tyrosine phosphorylation of a focal adhesion-associated protein, paxillin. Forskolin, a direct activator of adenylate cyclase, and dibutyryl cAMP (Bt2 cAMP), a membrane permeable cAMP analogue, potently inhibited Ang II-stimulated protein synthesis. However, they did not inhibit Ang II-induced activation of Ras and MAP kinases. Although both forskolin and Bt2 cAMP potently reduced background tyrosine phosphorylation of paxillin, they allowed Ang II to induce the same reaction. These results indicate that increasing cAMP antagonizes the hypertrophic response to Ang II without affecting Ras and MAP kinase activation in VSMC and suggest that it does not interrupt signaling from the Ang II receptor to focal adhesions.
References
Sep 1, 1992·Circulation Research·T TsudaM Yokoyama
Oct 1, 1990·Molecular and Cellular Biology·A J NaftilanA S Kraft
Nov 1, 1990·The Journal of Clinical Investigation·H ItohV J Dzau
Apr 1, 1989·Hypertension·B C BerkT Tsuda
May 1, 1989·The Journal of Clinical Investigation·U C Garg, A Hassid
Dec 1, 1989·Atherosclerosis·K KariyaY Takai
Apr 1, 1989·The Journal of Clinical Investigation·A J NaftilanV J Dzau
Jan 15, 1988·Biochemical and Biophysical Research Communications·Y KawaharaY Takai
Sep 1, 1985·Experimental Cell Research·C LoesbergP G de Groot
Sep 1, 1985·Journal of Cellular Physiology·B JonzonB B Fredholm
Apr 1, 1988·Circulation Research·A A GeisterferG K Owens
Oct 1, 1984·Atherosclerosis·J Nilsson, A G Olsson
Feb 1, 1982·The Journal of Cell Biology·S GuntherM A Gimbrone
Sep 7, 1995·Annals of the New York Academy of Sciences·J D GravesE G Krebs
Jul 17, 1995·FEBS Letters·M OkudaM Yokoyama
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·L M GravesE G Krebs
Apr 14, 1995·Science·E A Clark, J S Brugge
Mar 3, 1995·The Journal of Biological Chemistry·I Leduc, S Meloche
Apr 26, 1996·The Journal of Biological Chemistry·B SchiefferK E Bernstein
Jun 14, 1996·The Journal of Biological Chemistry·S EguchiT Inagami
Citations
Jan 5, 2002·Peptides·M LuodonpääH Ruskoaho
Aug 6, 2000·British Journal of Pharmacology·A SachinidisJ Hoppe
Mar 11, 2000·Acta Physiologica Scandinavica·M HouL Edvinsson
May 17, 2000·Pediatric Research·E B IzevbigieP E Ray
Jan 20, 2010·Journal of Receptor and Signal Transduction Research·Jerry G WebbAyad A Jaffa
May 2, 2017·Canadian Journal of Physiology and Pharmacology·Estelle R Simo-CheyouAshok K Srivastava
Feb 7, 1998·Hypertension·T Force, J V Bonventre
Jan 9, 2019·PloS One·Eun Sil KangHan Geuk Seo
Feb 12, 2005·Journal of Cellular Physiology·Stéphane PelletierSylvain Meloche
Sep 12, 2000·Nature Cell Biology·A K Howe, R L Juliano
Feb 5, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Laurent LoufraniDaniel Henrion
Jun 20, 1997·The Journal of Biological Chemistry·T TakahashiM Yokoyama
Jun 24, 2000·Annals of the New York Academy of Sciences·T TakahashiM Yokoyama
Jan 31, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Marja LuodonpääHeikki Ruskoaho
Sep 15, 2001·American Journal of Physiology. Heart and Circulatory Physiology·J G WebbS M Lanier
Nov 16, 1999·Biochimica Et Biophysica Acta·H HägerstrandA Iglic